JP2017105790A5 - - Google Patents

Download PDF

Info

Publication number
JP2017105790A5
JP2017105790A5 JP2017004063A JP2017004063A JP2017105790A5 JP 2017105790 A5 JP2017105790 A5 JP 2017105790A5 JP 2017004063 A JP2017004063 A JP 2017004063A JP 2017004063 A JP2017004063 A JP 2017004063A JP 2017105790 A5 JP2017105790 A5 JP 2017105790A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
prg4
composition according
effective amount
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017004063A
Other languages
English (en)
Japanese (ja)
Other versions
JP6483164B2 (ja
JP2017105790A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017105790A publication Critical patent/JP2017105790A/ja
Publication of JP2017105790A5 publication Critical patent/JP2017105790A5/ja
Application granted granted Critical
Publication of JP6483164B2 publication Critical patent/JP6483164B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017004063A 2009-05-22 2017-01-13 Prg4及びその治療調節作用の応用及び使用 Expired - Fee Related JP6483164B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18052509P 2009-05-22 2009-05-22
US61/180,525 2009-05-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014241399A Division JP6159704B2 (ja) 2009-05-22 2014-11-28 Prg4及びその治療調節作用の応用及び使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018200467A Division JP2019048824A (ja) 2009-05-22 2018-10-25 Prg4及びその治療調節作用の応用及び使用

Publications (3)

Publication Number Publication Date
JP2017105790A JP2017105790A (ja) 2017-06-15
JP2017105790A5 true JP2017105790A5 (https=) 2017-10-26
JP6483164B2 JP6483164B2 (ja) 2019-03-13

Family

ID=43126811

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012512085A Pending JP2012527485A (ja) 2009-05-22 2010-05-24 Prg4及びその治療調節作用の応用及び使用
JP2014241399A Expired - Fee Related JP6159704B2 (ja) 2009-05-22 2014-11-28 Prg4及びその治療調節作用の応用及び使用
JP2017004063A Expired - Fee Related JP6483164B2 (ja) 2009-05-22 2017-01-13 Prg4及びその治療調節作用の応用及び使用
JP2018200467A Pending JP2019048824A (ja) 2009-05-22 2018-10-25 Prg4及びその治療調節作用の応用及び使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012512085A Pending JP2012527485A (ja) 2009-05-22 2010-05-24 Prg4及びその治療調節作用の応用及び使用
JP2014241399A Expired - Fee Related JP6159704B2 (ja) 2009-05-22 2014-11-28 Prg4及びその治療調節作用の応用及び使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018200467A Pending JP2019048824A (ja) 2009-05-22 2018-10-25 Prg4及びその治療調節作用の応用及び使用

Country Status (7)

Country Link
US (2) US9730865B2 (https=)
EP (1) EP2432492B1 (https=)
JP (4) JP2012527485A (https=)
CN (1) CN102711796A (https=)
CA (2) CA2762989C (https=)
ES (1) ES2532526T3 (https=)
WO (1) WO2010135736A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2762989C (en) 2009-05-22 2021-04-13 Benjamin Sullivan Prg4 for treatment of oral cavity boundary lubrication disorders
WO2011091000A2 (en) * 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
WO2015060935A1 (en) 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions
US20150141328A1 (en) * 2013-11-18 2015-05-21 The Schepens Eye Research Institute Stimulation of human meibomian gland function
EP3074022B1 (en) * 2013-11-26 2022-03-30 Lubris LLC Compositions and methods for inhibiting intercellular interactions
EP2896429B1 (en) * 2014-01-20 2018-07-18 COR S.a.r.l. Skin Protector
RU2017129880A (ru) 2015-01-26 2019-03-04 ЛУБРИС ЭлЭлСи Применение prg4 в качестве противовоспалительного средства
MA42148A (fr) * 2015-05-19 2018-04-04 Lubris Llc Utilisation de prg4 pour améliorer l'acuité visuelle dynamique et les aberrations d'ordre supérieur
WO2016207299A1 (en) * 2015-06-23 2016-12-29 Fertin Pharma A/S Chewing gum composition for use in alleviation of xerostomia induced by radiotherapy treatment
CN105055949A (zh) * 2015-08-10 2015-11-18 孙霞 一种治疗小儿口腔溃疡的中药
CN108157358A (zh) * 2018-03-02 2018-06-15 沈阳汇翼宁消毒科技有限公司 一种消毒液及其制备方法
BR112020025148A2 (pt) * 2018-06-21 2021-03-09 Lubris Llc Lubricina para uso na cicatrização de feridas
WO2020097345A1 (en) * 2018-11-08 2020-05-14 The Schepens Eye Research Institute, Inc. Therapeutic approaches for tissue reconstruction and wound healing treatment
WO2020136606A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
EP3902523A1 (en) 2018-12-29 2021-11-03 3M Innovative Properties Company Oral articles and methods of use
BR112021024266A2 (pt) 2019-06-14 2022-01-11 Procter & Gamble Composições para tratamento bucal sem enxágue
WO2020248232A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
EP3982913A1 (en) 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
WO2020248239A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
EP3982912A1 (en) 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
JP7272214B2 (ja) * 2019-09-24 2023-05-12 日油株式会社 デンタルプラーク・ステイン付着防止剤および口腔用組成物
CN111944595B (zh) * 2020-08-21 2022-08-09 健尔康医疗科技股份有限公司 一种医用外科器械用润滑剂及其制备和使用方法
KR20250152087A (ko) * 2023-10-10 2025-10-22 파인·바이오메디컬 유겐가이샤 순환액 및 윤활성 조정제

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002977A1 (en) * 1980-04-25 1981-10-29 Orthana Kemisk Fab As Sterilized,preserved,stable mucine-containing solutions and sterilization method
US4938963A (en) * 1988-11-22 1990-07-03 Parnell Pharmaceuticals, Inc. Method and composition for treating xerostomia
US6433142B1 (en) 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US5326558A (en) 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
US6743774B1 (en) 1999-04-23 2004-06-01 Rhode Island Hospital Tribonectins
US7001881B1 (en) 1999-04-23 2006-02-21 Rhode Island Hospital Tribonectins
US6960562B2 (en) 1999-04-23 2005-11-01 Rhode Island Hospital, A Lifespan Partner Tribonectin polypeptides and uses thereof
GB2361870A (en) * 2000-05-03 2001-11-07 Zia Hashmi Treating xerostomia
EP1347993A2 (en) * 2000-12-29 2003-10-01 Glaxo Group Limited Superficial zone protein and methods of making and using same
US7071228B2 (en) * 2002-10-23 2006-07-04 Parks L Dean Method of treating musculoskeletal and connective tissue inflammations
US7415381B2 (en) 2003-01-09 2008-08-19 Rhode Island Hospital, A Lifespan Partner Joint friction sensing
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
WO2005000331A2 (en) 2003-06-04 2005-01-06 Mucosal Therapeutics, Inc. Compositions for the treatment and prevention of degenerative joint disorders
DK1663291T3 (da) * 2003-08-14 2012-07-02 Wyeth Llc Rekombinante lubricinmolekyler og anvendelser deraf
CA2558497A1 (en) 2004-03-05 2005-09-15 Synthes (U.S.A.) Use of a mixture for the production of an agent for treating defective or degenerated cartilage in the production of natural cartilage replacement in vitro
US8034796B2 (en) * 2004-04-07 2011-10-11 The University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
WO2005102363A2 (en) 2004-04-20 2005-11-03 Mucosal Therapeutics Llc Methods of promoting cartilage healing or cartilage integration
EP1778360A2 (en) 2004-07-23 2007-05-02 Mucosal Therapeutics LLC Compositions and methods for viscosupplementation
BRPI0514037B8 (pt) 2004-08-02 2021-05-25 Glaxo Group Ltd composição para o cuidado oral
WO2006060473A2 (en) * 2004-12-03 2006-06-08 Mucosal Therapeutics Llc Methods of treatment of injured or diseased joints with lubricin compositions
US20070111327A1 (en) 2005-05-05 2007-05-17 Jay Gregory D Methods of detecting lubricin
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US20090068247A1 (en) 2007-09-12 2009-03-12 Mucosal Therapeutics Biocompatible devices coated with a tribonectin and methods for their production
US20090104148A1 (en) 2007-09-18 2009-04-23 Jay Gregory D Treatment and prevention of joint disease
HUE024146T2 (en) 2008-05-07 2016-02-29 Univ California Medical filling and enrichment of eye surface lubrication
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
CN102239368A (zh) * 2008-12-19 2011-11-09 考泰斯德事隆Cvs有限公司 车辆液体加热器
US8980840B2 (en) 2009-01-13 2015-03-17 Schepens Eye Research Institute Therapeutic modulation of vaginal epithelium boundary lubrication
CA2762989C (en) 2009-05-22 2021-04-13 Benjamin Sullivan Prg4 for treatment of oral cavity boundary lubrication disorders
WO2011019963A2 (en) 2009-08-13 2011-02-17 Singularis, Inc. Prg4 treatment for interstitial cystitis
WO2011091000A2 (en) 2010-01-19 2011-07-28 Singularis, Inc. Oral care compositions and methods
US20130116186A1 (en) 2011-10-04 2013-05-09 Rhode Island Hospital, A Lifespan Partner Lubricin injections to maintain cartilage health
WO2015060935A1 (en) 2013-10-22 2015-04-30 Lubris, Llc Control of rheological properties of mixed hyaluronate/lubricin solutions

Similar Documents

Publication Publication Date Title
JP2017105790A5 (https=)
JP6483164B2 (ja) Prg4及びその治療調節作用の応用及び使用
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
JP2017505338A5 (https=)
RU2010101892A (ru) Гиалуронидаза и способ ее применения
NZ600544A (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
RU2013139651A (ru) Новые соединения, влияющие на пищевое поведение
ES2866957T3 (es) Agente terapéutico del síndrome de Hunter y método de tratamiento
RU2012136530A (ru) Новые соединения, влияющие на пищевое поведение
ES2585253T3 (es) Composiciones para prevenir la pérdida de cabello o para estimular el crecimiento del cabello
RU2015123315A (ru) Пептиды, стимулирующие подкожный адипогенез
JP2016501866A5 (https=)
EP4144362A1 (en) Compositions comprising short-acting hormones for treating or preventing obesity and pumps comprising said composition
CN108135965B (zh) 用于伤口愈合的含p物质的药物组合物
JP2013543378A5 (https=)
JP2012508195A (ja) インターロイキン−1及びペプチドを含有する組成物
JP2009500045A5 (https=)
ES2462501T3 (es) Composición que comprende VIP o sus fragmentos activos para su uso en el tratamiento de la fibrosis aórtica
RU2008134118A (ru) Внутрижелудочковая доставка белка при боковом амиотрофическом склерозе
JP2022502359A5 (https=)
JP2010524910A5 (https=)
ES2255988T3 (es) Utilizacion de una emulsion de aceite en agua para la preparacion de un medicamento.
JP2007050126A (ja) 美容方法
Liu et al. New alternative therapy for orofacial localized scleroderma